Patrick J. Heron, Director at Mirum Pharmaceuticals, Inc. (MIRM), bought 549 shares at $43.93 ($24K) on 2025-03-17, disclosed to the SEC on 2025-03-18.
Open-market purchase of $24k MIRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.11 | 528 | $23K | 96.2% |
| 2 | $43.93 | 21 | $923 | 3.8% |
| Total | $44.10 avg | 549 | $24K | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |